Flavivirus RNA cap methyltransferase: structure, function, and inhibition.

Authors: Liu L,Dong H,Chen H,Zhang J,Ling H,Li Z,Shi PY,Li H,
Address: Wadsworth Center, New York State Department of Health, 120 New Scotland Ave, Albany, NY 12208, USA.
Journal: Front Biol.


Publication: 2010 Aug 1;5(4):286-303.
Free Text: Flavivirus RNA cap methyltransferase: structure, function, and inhibition.

abstract

Many Flaviviruses are significant human pathogens. The plus-strand RNA genome of a flavivirus contains a 5' terminal cap 1 structure (m(7)GpppAmG). The flavivirus encodes one methyltransferase (MTase), located at the N-terminal portion of the NS5 RNA-dependent RNA polymerase (RdRp). Here we review recent advances in our understanding of flaviviral capping machinery and the implications for drug development. The NS5 MTase catalyzes both guanine N7 and ribose 2'-OH methylations during viral cap formation. Representative flavivirus MTases, from dengue, yellow fever, and West Nile virus (WNV), sequentially generate GpppA → m(7)GpppA → m(7)GpppAm. Despite the existence of two distinct methylation activities, the crystal structures of flavivirus MTases showed a single binding site for S-adenosyl-L-methionine (SAM), the methyl donor. This finding indicates that the substrate GpppA-RNA must be repositioned to accept the N7 and 2'-O methyl groups from SAM during the sequential reactions. Further studies demonstrated that distinct RNA elements are required for the methylations of guanine N7 on the cap and of ribose 2'-OH on the first transcribed nucleotide. Mutant enzymes with different methylation defects can trans complement one another in vitro, demonstrating that separate molecules of the enzyme can independently catalyze the two cap methylations in vitro. In the context of the infectious virus, defects in both methylations, or a defect in the N7 methylation alone, are lethal to WNV. However, viruses defective solely in 2'-O methylation are attenuated and can protect mice from later wild-type WNV challenge. The results demonstrate that the N7 methylation activity is essential for the WNV life cycle and, thus, methyltransferase represents a novel and promising target for flavivirus therapy.



Related Articles
Structure and function of flavivirus NS5 methyltransferase.
J Virol. 2007
Structure and function of flavivirus NS5 methyltransferase.
Zhou Y, Ray D, Zhao Y, Dong H, Ren S, Li Z, Guo Y, Bernard KA, Shi PY, Li H. J Virol. 2007 Apr; 81(8):3891-903. Epub 2007 Jan 31.
Review Flavivirus methyltransferase: a novel antiviral target.
Antiviral Res. 2008
Review Flavivirus methyltransferase: a novel antiviral target.
Dong H, Zhang B, Shi PY. Antiviral Res. 2008 Oct; 80(1):1-10. Epub 2008 Jun 5.
West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5.
J Virol. 2006
West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5.
Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, Deas TS, Zhou Y, Li H, Shi PY. J Virol. 2006 Sep; 80(17):8362-70.
West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism.
J Virol. 2008
West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism.
Dong H, Ren S, Zhang B, Zhou Y, Puig-Basagoiti F, Li H, Shi PY. J Virol. 2008 May; 82(9):4295-307. Epub 2008 Feb 27.
Review Chapter 2. New insights into flavivirus nonstructural protein 5.
Adv Virus Res. 2009
Review Chapter 2. New insights into flavivirus nonstructural protein 5.
Davidson AD. Adv Virus Res. 2009; 74:41-101.
Crystal structure of RlmM, the 2'O-ribose methyltransferase for C2498 of Escherichia coli 23S rRNA.
Nucleic Acids Res. 2012
Crystal structure of RlmM, the 2'O-ribose methyltransferase for C2498 of Escherichia coli 23S rRNA.
Punekar AS, Shepherd TR, Liljeruhm J, Forster AC, Selmer M. Nucleic Acids Res. 2012 Nov 1; 40(20):10507-20. Epub 2012 Aug 25.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.